Literature DB >> 19225233

Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.

S Rolstad1, A Nordlund, C Eckerström, M H Gustavsson, H Zetterberg, A Wallin.   

Abstract

BACKGROUND: The concept of the cognitive reserve (CR) posits that factors such as education enable compensation for the effect of brain pathology. Consequently, pathology should be more pronounced in individuals with higher CR before becoming clinically apparent. Biomarkers such as total tau (t-tau) and beta-amyloid 42 (Abeta42) may be surrogates for pathology in relation to CR in patients with neurodegenerative disease.
OBJECTIVE: To examine the applicability of biomarkers as surrogates for pathology in relation to the CR in patients with mild cognitive impairment (MCI) either converting to dementia or remaining stable at follow-up.
METHOD: Comparisons of baseline t-tau, Abeta42, educational years and global cognition for MCI patients either converting to dementia (n = 57) or remaining stable (n = 91) were made. Patients converting to dementia were grouped on the basis of educational level and compared considering biomarkers and neuropsychological tests.
RESULTS: Stable MCI patients were better educated, performed better cognitively, had higher Abeta42 levels and lower levels of t-tau. Converting MCI patients with higher education had lower levels of Abeta42 and performed equally in neuropsychological tests compared to those with lower education.
CONCLUSION: Our results suggest that highly educated MCI patients subsequently converting to dementia display more amyloid pathology. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225233     DOI: 10.1159/000203130

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  12 in total

1.  Age and diagnostic performance of Alzheimer disease CSF biomarkers.

Authors:  N Mattsson; E Rosén; O Hansson; N Andreasen; L Parnetti; M Jonsson; S-K Herukka; W M van der Flier; M A Blankenstein; M Ewers; K Rich; E Kaiser; M M Verbeek; M Olde Rikkert; M Tsolaki; E Mulugeta; D Aarsland; P J Visser; J Schröder; J Marcusson; M de Leon; H Hampel; P Scheltens; A Wallin; M Eriksdotter-Jönhagen; L Minthon; B Winblad; K Blennow; H Zetterberg
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

Review 2.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

Review 3.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

Review 4.  Beta-amyloid deposition and the aging brain.

Authors:  Karen M Rodrigue; Kristen M Kennedy; Denise C Park
Journal:  Neuropsychol Rev       Date:  2009-11-12       Impact factor: 7.444

5.  Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Shanshan Li; Mei-Cheng Wang; Abhay Moghekar; Ola A Selnes; Marilyn Albert; Richard O'Brien
Journal:  Neurobiol Aging       Date:  2013-08-01       Impact factor: 4.673

6.  Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study.

Authors:  Anna Grahn; Staffan Nilsson; Arto Nordlund; Thomas Lindén; Marie Studahl
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 6.682

Review 7.  Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions.

Authors:  Luciana Mascarenhas Fonseca; Anna Carolina Rufino Navatta; Cássio M C Bottino; Eliane Correa Miotto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-09-18

8.  Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders.

Authors:  Yasser Iturria-Medina; Roberto C Sotero; Paule J Toussaint; Alan C Evans
Journal:  PLoS Comput Biol       Date:  2014-11-20       Impact factor: 4.475

9.  Vascular risk as a predictor of cognitive decline in a cohort of elderly patients with mild to moderate dementia.

Authors:  Pedro K Curiati; Regina M Magaldi; Claudia K Suemoto; Cassio M C Bottino; Ricardo Nitrini; José Marcelo Farfel; Wilson Jacob-Filho
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-10-29

Review 10.  Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Craig Ritchie; Nadja Smailagic; Anna H Noel-Storr; Yemisi Takwoingi; Leon Flicker; Sam E Mason; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.